The CPI(M) has urged the Indian government to issue a compulsory license for Remdesivir to facilitate generic manufacturing. Additionally, the EPO has developed new patent search strategies for COVID-19, and an upcoming EUIPO-EPO conference will address intellectual property issues in additive manufacturing.
Read more about CPI(M) asks Government to issue compulsory license for Remdesivir, EPO creates search strategies to help fight against COVID-19 and more patent news